These leaders will identify and advance high-potential assets from preclinical through Phase 1 clinical stages, shape early partnering strategies, and drive transactions in collaboration with Business Development
Job Summary
These leaders will identify and advance high-potential assets from preclinical through Phase 1 clinical stages, shape early partnering strategies, and drive transactions in collaboration with Business Development.
Serve as the senior Early S&E leader within the TALT, influencing therapeutic strategy and ensuring external innovation priorities are integrated into portfolio planning.
CSL Behring is a global biotherapeutics leader driven by our promise to save lives, focused on serving patients’ needs by using the latest technologies.
Matching Summary
These leaders will identify and advance high-potential assets from preclinical through Phase 1 clinical stages, shape early partnering strategies, and drive transactions in collaboration with Business Development.
Skills & Requirements
Must-have
external innovation sourcing
early-stage asset evaluation
Hematology or Cardiovascular/Renal expertise
lead due diligence
develop partnering strategies
cultivate external relationships
Nice-to-have
influence therapeutic strategy
integrate portfolio planning
cross-functional team leadership
competitive positioning
Key Requirements
Advanced degree required (PhD, MD, or equivalent)
Significant tenure in biopharma
Significant experience in external innovation, search & evaluation, or business development
Proven track record of leading due diligence and closing early-stage deals
Strong network within biotech, academia, and pharma BD organizations